ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Patient death sparks safety worries in Ionis trial
pharmafile
May 17, 2017Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy and the results were extremely positive, except for the side-effects.
Pharma Sources Insight January 2025
